Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Metastatic Colorectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Huazhong University of Science and Technology, Wuhan, Hubei, China
Contact: Study coordinator (Xianglin Yuan, PhD,MD) · Xlyuan1020@163.com · 13667241722

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Immunotheray Combined With Simvastatin and Target Therapy and Chemotharepy for Advanced Colorectal Cancer

Metastatic Colorectal Cancer

Abroad (travel likely)RecruitingPHASE2

Nanjing, China · Nanjing, China

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Metastatic Bone Sarcoma · Metastatic Malignant Neoplasm in the Lung · Metastatic Soft Tissue Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Buffalo, United States

A Study of YL202 in Patients With Advanced Solid Tumors

Non Small Cell Lung Cancer · Colorectal Cancer · Cervical Cancer

Abroad (travel likely)RecruitingPHASE2

Changsha, China

Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.

Colorectal Cancer · Colorectal Adenocarcinoma · Rectal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Lyon, France · Marseille, France